Bionano Genomics (BNGO) announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 39.68M shares at an offering price of 25.c per share of common stock. The closing of the offering is expected to occur on or about January. H.C. Wainwright is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the company from the offering are expected to be approximately $10M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- BioNano Genomics Restructures Debt to Boost Liquidity
- Bionano Genomics announces publication in Modern Pathology on OGM
- Bionano Genomics urges stockholders to support proposals at special meeting
- Bionano Genomics announces presentations at ASH annual meeting
- Ladenburg downgrades Bionano Genomics on restructuring uncertainty